Virtus ETF Advisers LLC Avidity Biosciences, Inc. Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,106 shares of RNA stock, worth $64,527. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,106

Previous 2,305 8.63%

Holding current value

$64,527

Previous $105,000 41.9%

% of portfolio

0.03%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$29.08 - $52.5 $5,786 - $10,447	-199 Reduced 8.63%	2,106 $61,000
Q3 2024 Nov 14, 2024	BUY	$37.21 - $48.14 $1,488 - $1,925	40 Added 1.77%	2,305 $105,000
Q2 2024 Aug 14, 2024	SELL	$22.73 - $40.85 $193,750 - $348,205	-8,524 Reduced 79.01%	2,265 $92,000
Q1 2024 May 15, 2024	SELL	$9.16 - $25.52 $6,778 - $18,884	-740 Reduced 6.42%	10,789 $275,000
Q4 2023 Feb 15, 2024	BUY	$4.87 - $9.37 $16,635 - $32,007	3,416 Added 42.11%	11,529 $104,000
Q3 2023 Nov 07, 2023	SELL	$6.3 - $11.35 $5,084 - $9,159	-807 Reduced 9.05%	8,113 $51,000
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $31,743 - $51,829	2,989 Added 50.4%	8,920 $98,000
Q1 2023 May 15, 2023	SELL	$15.35 - $25.65 $35,059 - $58,584	-2,284 Reduced 27.8%	5,931 $91,000
Q4 2022 Feb 14, 2023	SELL	$10.06 - $22.66 $6,408 - $14,434	-637 Reduced 7.2%	8,215 $182,000
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $1,097 - $1,663	71 Added 0.81%	8,852 $145,000
Q2 2022 Aug 12, 2022	BUY	$11.18 - $20.5 $27,894 - $51,147	2,495 Added 39.69%	8,781 $128,000
Q1 2022 May 16, 2022	SELL	$14.2 - $23.78 $5,367 - $8,988	-378 Reduced 5.67%	6,286 $116,000
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $31,109 - $43,706	-1,525 Reduced 18.62%	6,664 $158,000
Q3 2021 Nov 15, 2021	SELL	$18.16 - $25.21 $7,699 - $10,689	-424 Reduced 4.92%	8,189 $202,000
Q2 2021 Aug 10, 2021	SELL	$19.62 - $29.26 $10,300 - $15,361	-525 Reduced 5.75%	8,613 $213,000
Q1 2021 May 17, 2021	BUY	$20.28 - $28.15 $3,366 - $4,672	166 Added 1.85%	9,138 $199,000
Q4 2020 Feb 12, 2021	BUY	$24.73 - $35.12 $221,877 - $315,096	8,972 New	8,972 $229,000

Others Institutions Holding RNA

# of Institutions

258

Shares Held

108M

Call Options Held

517K

Put Options Held

717K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.6B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Avidity Biosciences, Inc. Transaction History